CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel. [electronic resource]
Producer: 20131118Description: 1472-8 p. digitalISSN:- 1569-8041
- Adult
- Black or African American -- genetics
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Aryl Hydrocarbon Hydroxylases -- genetics
- Breast Neoplasms -- drug therapy
- Cohort Studies
- Cytochrome P-450 CYP2C8
- Female
- Genetic Variation -- genetics
- Humans
- Middle Aged
- Paclitaxel -- adverse effects
- Paraneoplastic Polyneuropathy -- chemically induced
- Risk Factors
- Treatment Outcome
- White People -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.